TDMx for Gentamicin

for Gentamicin in peadiatric oncology patients

Version: 0.95.5 beta / Built 20170821

Disclaimer:

TDMx has been created for personal use only. The use of any result generated by TDMx is in any case the sole risk and responsibility of the TDMx user. Therapeutic decision should not solely rely on TDMx as information provided by TDMx does not replace clinical judgement. Although TDMx has been validated carefully, there is no guarantee for the accuracy of the provided results.

When using TDMx, you automatically agree with this disclaimer and the legal notices!

Dr. Sebastian G. Wicha

c/o University of Hamburg, Germany

Dr. Stefanie Hennig, Carolina LLanos-Paez

c/o University of Queensland, Brisbane, Australia

Information to users:

This is a beta version! You can improve TDMx by reporting any bug/issue you observed! Just email us!

References

Population PK model (paediatric oncology patients): Llanoz-Paez et al. Antimicrobial Agents Chemother, 2017: 61; e00208-17

R Core Team (2014). R: A language and environment for statistical computing. R Foundation for Statistical Computing, Vienna, Austria.

Demographics

Age [yrs.]

Weight [kg]

Height [cm]

Sex

Dose [mg] | Infusion dur. [h]

Dosing interval (for next dose) [h]

Laboratory

Serum creatinine [umol/L]

MIC [mg/L]

Measured gentamicin [mg/L]

Time [dd/mm/yyyy/hh:mm]

Dose [mg]

Infusion duration [h]

cGentamicin [mg/L]